Peter Gunvén

3.4k total citations · 2 hit papers
46 papers, 2.6k citations indexed

About

Peter Gunvén is a scholar working on Oncology, Hepatology and Pathology and Forensic Medicine. According to data from OpenAlex, Peter Gunvén has authored 46 papers receiving a total of 2.6k indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Oncology, 15 papers in Hepatology and 13 papers in Pathology and Forensic Medicine. Recurrent topics in Peter Gunvén's work include Hepatocellular Carcinoma Treatment and Prognosis (15 papers), Lymphoma Diagnosis and Treatment (11 papers) and Viral-associated cancers and disorders (10 papers). Peter Gunvén is often cited by papers focused on Hepatocellular Carcinoma Treatment and Prognosis (15 papers), Lymphoma Diagnosis and Treatment (11 papers) and Viral-associated cancers and disorders (10 papers). Peter Gunvén collaborates with scholars based in Sweden, Japan and United States. Peter Gunvén's co-authors include Susumu Yamazaki, Hiroshi Hasegawa, T Kosuge, Hideo Hasegawa, Hideo Ozaki, M Makuuchi, Tadatoshi Takayama, K Takayasu, Taira Kinoshitá and Keiichi Maruyama and has published in prestigious journals such as Nature, Proceedings of the National Academy of Sciences and JNCI Journal of the National Cancer Institute.

In The Last Decade

Peter Gunvén

45 papers receiving 2.5k citations

Hit Papers

Preoperative portal embolization to increase safety of ma... 1989 2026 2001 2013 1990 1989 250 500 750

Peers

Peter Gunvén
J R Goepel United Kingdom
Young Hwan Koh South Korea
David L. Bartlett United States
C Bognel France
Peter Gunvén
Citations per year, relative to Peter Gunvén Peter Gunvén (= 1×) peers Manabu Morimoto

Countries citing papers authored by Peter Gunvén

Since Specialization
Citations

This map shows the geographic impact of Peter Gunvén's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter Gunvén with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter Gunvén more than expected).

Fields of papers citing papers by Peter Gunvén

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Peter Gunvén. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter Gunvén. The network helps show where Peter Gunvén may publish in the future.

Co-authorship network of co-authors of Peter Gunvén

This figure shows the co-authorship network connecting the top 25 collaborators of Peter Gunvén. A scholar is included among the top collaborators of Peter Gunvén based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Peter Gunvén. Peter Gunvén is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Gunvén, Peter, et al.. (2010). Gene expression profiling guiding diagnosis and therapy of rare mammary-like anogenital gland carcinomas. Medical Oncology. 29(1). 127–132. 4 indexed citations
2.
Gunvén, Peter, Eduard Jonas, Henric Blomgren, et al.. (2010). Undetectable late hepatic sequelae after hypofractionated stereotactic radiotherapy for liver tumors. Medical Oncology. 28(4). 958–965. 3 indexed citations
3.
Gunvén, Peter, Henric Blomgren, Ingmar Lax, & Seymour H. Levitt. (2008). Curative stereotactic body radiotherapy for liver malignancy. Medical Oncology. 26(3). 327–334. 10 indexed citations
5.
Vitols, Sigurd, Peter Gunvén, Astrid Gruber, & Olle Larsson. (1996). Expression of the low-density lipoprotein receptor, HMG-CoA reductase, and multidrug resistance (Mdr1) genes in colorectal carcinomas. Biochemical Pharmacology. 52(1). 127–131. 12 indexed citations
6.
Arnér, Elias S.J., Otte Brosjö, Peter Gunvén, et al.. (1995). Expression of deoxycytidine kinase and phosphorylation of 2-chlorodeoxyadenosine in human normal and tumour cells and tissues. European Journal of Cancer. 31(2). 202–208. 81 indexed citations
7.
Zelada-Hedman, M, Lennart Iselius, Peter Gunvén, et al.. (1994). Genetic rearrangements in sporadic and familial gastric carcinomas detected with microsatellite markers.. PubMed. 20(6). 667–73. 7 indexed citations
8.
Eriksson, Staffan, Elias S.J. Arnér, Tatjana Spasokoukotskaja, et al.. (1994). Properties and levels of deoxynucleoside kinases in normal and tumor cells; implications for chemotherapy. Advances in Enzyme Regulation. 34. 13–25. 62 indexed citations
9.
Shimamura, Y, et al.. (1990). Juxtacaval Liver Resections with the Use of an Internal IVC Shunt Tube. HPB Surgery. 2(2). 121–127. 7 indexed citations
10.
Shimamura, Y, et al.. (1990). Endoscopic laser coagulation through an optical laser balloon. Lasers in Surgery and Medicine. 10(1). 25–27. 4 indexed citations
11.
Hasegawa, Hiroshi, Masatoshi Makuuchi, Susumu Yamazaki, & Peter Gunvén. (1989). Central bisegmentectomy of the liver: Experience in 16 patients. World Journal of Surgery. 13(6). 786–790. 29 indexed citations
12.
Makuuchi, Masatoshi, Tadatoshi Takayama, Peter Gunvén, et al.. (1989). Restrictive versus liberal blood transfusion policy for hepatectomies in cirrhotic patients. World Journal of Surgery. 13(5). 644–648. 96 indexed citations
13.
Shimamura, Y, Peter Gunvén, Yasuo Shima, et al.. (1988). Combined peripheral and central chemoembolization of liver tumors.Experience with lipiodol-doxorubicin and gelatin sponge (L-TAE). Cancer. 61(2). 238–242. 58 indexed citations
14.
Makuuchi, Masatoshi, Takaaki Mori, Peter Gunvén, Susumu Yamazaki, & Hiroshi Hasegawa. (1987). Safety of hemihepatic vascular occlusion during resection of the liver.. PubMed. 164(2). 155–8. 306 indexed citations
15.
Gunvén, Peter, George Klein, Eva Klein, Torsten Norin, & Surjit Singh. (1980). Surface immunoglobulins on Burkitt's lymphoma biopsy cells from 91 patients. International Journal of Cancer. 25(6). 711–719. 33 indexed citations
16.
Gunvén, Peter, George Klein, John L. Ziegler, et al.. (1978). Epstein-Barr Virus-Associated and Other Antiviral Antibodies During Intense BCG Administration to Patients With Burkitt's Lymphoma in Remission 2. JNCI Journal of the National Cancer Institute. 60(1). 31–37. 6 indexed citations
17.
Gunvén, Peter, George Klein, Peter Clifford, & Surjit Singh. (1974). Epstein-Barr Virus-Associated Membrane-Reactive Antibodies During Long Term Survival After Burkitt's Lymphoma. Proceedings of the National Academy of Sciences. 71(4). 1422–1426. 16 indexed citations
18.
Oldstone, Michael B. A., Argyrios N. Theofilopoulos, Peter Gunvén, & George Klein. (1974). Immune Complexes Associated with Neoplasia: Presence of Epstein-Barr Virus Antigen-Antibody Complexes in Burkitt’s Lymphoma. Intervirology. 4(5). 292–302. 46 indexed citations
19.
Gunvén, Peter, George Klein, Gertrude Henle, et al.. (1973). Antibodies Associated With Epstein-Barr Virus in Burkitt's Lymphoma During Injections of BCG or Irradiated Autochthonous Tumor Cells2. JNCI Journal of the National Cancer Institute. 51(1). 45–56. 8 indexed citations
20.
Cochran, Alistair J., Rolf Kiessling, Eva Klein, Peter Gunvén, & Alan K. Foulis. (1973). Human Tumor Cell Migration2. JNCI Journal of the National Cancer Institute. 51(4). 1109–1111. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026